Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
Fund Manager Portfolios
Gain insights from the world's largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Search
Sign in
Sign up
Doximity
DOCS
Market cap
$12.6B
Overview
Fund Trends
Analyst Outlook
Journalist POV
67.52
USD
+0.02
0.03%
At close
Updated
Oct 14, 3:04 PM EDT
Pre-market
After hours
1D
5D
1M
3M
6M
YTD
1Y
5Y
10Y
1 day
0.03%
5 days
-6.2%
1 month
-6.83%
3 months
9.7%
6 months
28.37%
Year to date
26.06%
1 year
60.92%
5 years
27.4%
10 years
27.4%
Positive
Neutral
Negative
Sentiment
3-Months
Positive
Neutral
56%
Negative
Positive
Neutral
Negative
Negative
Zacks Investment Research
3 days ago
Here's Why Doximity (DOCS) Fell More Than Broader Market
In the closing of the recent trading day, Doximity (DOCS) stood at $65.61, denoting a -9.59% move from the preceding trading day.
Positive
Zacks Investment Research
12 days ago
Can Doximity's New AI Suite Drive the Growth It Needs?
DOCS reports stronger Q1 results and is betting on its new AI suite -- Scribe, GPT, and Pathway -- to drive its next growth phase.
Neutral
Business Wire
12 days ago
Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation
SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating potential legal claims on behalf of Doximity, Inc. (NYSE: DOCS) shareholders, concerning alleged misconduct by certain officers and directors that may have harmed the company and its investors. Investors who have continuously held Doximity shares since before June 24, 2021, may have legal rights and are encouraged to contact the firm to learn more: https://www.johnsonfistel.com/investigations/doximity-inc-2 On May 13, 2025, the C.
Positive
Zacks Investment Research
18 days ago
HIMS vs. DOCS: Which Digital Health Platform Is a Better Investment?
Hims & Hers and Doximity are transforming digital health, but which leads in earnings growth and platform expansion? Let's see.
Neutral
Zacks Investment Research
25 days ago
Doximity (DOCS) Exceeds Market Returns: Some Facts to Consider
Doximity (DOCS) closed at $73.6 in the latest trading session, marking a +1.28% move from the prior day.
Negative
Zacks Investment Research
1 month ago
Doximity (DOCS) Increases Despite Market Slip: Here's What You Need to Know
Doximity (DOCS) closed at $71.03 in the latest trading session, marking a +1.1% move from the prior day.
Neutral
Business Wire
1 month ago
Doximity, Inc. Long-Term Shareholder Announcement: Johnson Fistel Encourages Investors to Reach Out For More Information About Continuing Investigation
SAN DIEGO--(BUSINESS WIRE)--Johnson Fistel, PLLP is investigating potential legal claims on behalf of Doximity, Inc. (NYSE: DOCS) shareholders, concerning alleged misconduct by certain officers and directors that may have harmed the company and its investors. Investors who have continuously held Doximity shares since before June 24, 2021, may have legal rights and are encouraged to contact the firm to learn more: https://www.johnsonfistel.com/investigations/doximity-inc-2 On May 13, 2025, the C.
Positive
Zacks Investment Research
2 months ago
DOCS Stock Up in Pre-Market Post Q1 Earnings Beat, Gross Margin Down
Doximity beats first-quarter fiscal 2026 estimates with double-digit revenue growth and lifts its full-year forecast.
Positive
Benzinga
2 months ago
Doximity Analysts Increase Their Forecasts After Strong Q1 Earnings
Doximity Inc DOCS reported better-than-expected earnings for the first quarter on Thursday.
Neutral
Seeking Alpha
2 months ago
Doximity, Inc. (DOCS) Q1 2026 Earnings Call Transcript
Doximity, Inc. (NYSE:DOCS ) Q1 2026 Earnings Conference Call August 7, 2025 5:00 PM ET Company Participants Anna Bryson - Chief Financial Officer Jeffrey A. Tangney - Co-Founder, CEO & Chairperson Perry Scott Gold - Head of Investor Relations Conference Call Participants Allen Charles Lutz - BofA Securities, Research Division Brian Christopher Peterson - Raymond James & Associates, Inc., Research Division Brian Gil Tanquilut - Jefferies LLC, Research Division Craig Matthew Hettenbach - Morgan Stanley, Research Division David Michael Larsen - BTIG, LLC, Research Division Elizabeth Hammell Anderson - Evercore ISI Institutional Equities, Research Division Jessica Elizabeth Tassan - Piper Sandler & Co., Research Division Michael Aaron Cherny - Leerink Partners LLC, Research Division Ryan Michael MacDonald - Needham & Company, LLC, Research Division Ryan Scott Daniels - William Blair & Company L.L.C.
Show more
See News Rankings
Sign up
Sign in
Fund Insights
Common Fund Bets
See what stocks and ETFs funds are collectively bullish/bearish on
Largest Fund Trades
Explore the largest stock and ETF buys and sells made by funds
Fund Manager Portfolios
Gain insights from the world's largest funds and super investors
Analyst Insights
Price Target Consensus
See what stocks research analysts are collectively bullish/bearish on
Latest Ratings Feed
Explore the latest ratings and price targets from the best equity research analysts
Equity Analyst Profiles
Browse analysts, their latest ratings and track record
Research Firm Profiles
Browse research firm recommendations, trends, and performance
WSR Indexes
Fund Manager Index
Stock index based on fund manager consensus updated each quarter
Analyst Index
COMING SOON - Stock index based on equity analyst consensus updated every second
Theme
Close